Stay updated on Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.3, replacing the previous v3.5.2. This reflects a small site update to how the record history is presented, with no impact on the trial information.
    Difference
    0.1%
    Check dated 2026-04-30T15:32:00.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision, v3.5.2, was added. The previous revision, v3.5.0, was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:06:59.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision v3.5.0 to the history and removed Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:12:07.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The history now lists the latest revision as v3.4.3 and removes v3.4.2. This is a backend/version update rather than changes to study data or core page content.
    Difference
    0.1%
    Check dated 2026-03-11T14:47:45.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added a new Revision: v3.4.2 entry to the history and removed older notices (including the lapse in government funding) and a prior Revision: v3.4.1 entry.
    Difference
    0.5%
    Check dated 2026-02-11T01:34:23.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    A site-wide funding notice was added. The record history shows a new revision (v3.4.1) replacing the previous (v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T23:29:51.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.